Religare Enterprises, a financial services arm of Ranbaxy Group, is planning to rise more than Rs 1,000 through rights offering to its existing shareholders. The company's board is expected to meet on 30th October to consider rising of funds over Rs 1,000 crore at around current price level by further issue of equity shares on rights basis.
Saturday, November 1, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment